The Vanguard Group 13D and 13G filings for Meridian Bioscience, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-09 11:27 am Purchase | 2022-12-30 | 13G | Meridian Bioscience, Inc. VIVO | The Vanguard Group | 4,970,105 11.340% | 93,163 (+1.91%) | Filing |
| 2022-02-10 08:27 am Purchase | 2021-12-31 | 13G | Meridian Bioscience, Inc. VIVO | The Vanguard Group | 4,876,942 11.210% | 119,227 (+2.51%) | Filing |
| 2021-02-10 11:28 am Purchase | 2020-12-31 | 13G | Meridian Bioscience, Inc. VIVO | The Vanguard Group | 4,757,715 11.030% | 155,889 (+3.39%) | Filing |